Human papillomavirus-associated cutaneous disease burden in human immunodeficiency virus (HIV)-positive patients: the role of human papillomavirus vaccination and a review of the literature.

about

Human papillomavirus-associated cutaneous disease burden in human immunodeficiency virus (HIV)-positive patients: the role of human papillomavirus vaccination and a review of the literature.

Item

http://www.wikidata.org/entity/Q45324643

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Human papillomavirus-associate ...... nd a review of the literature.

@en

Human papillomavirus-associated cutaneous disease burden in human immunodeficiency virus

@nl

type

Item

label

Human papillomavirus-associate ...... nd a review of the literature.

@en

Human papillomavirus-associated cutaneous disease burden in human immunodeficiency virus

@nl

prefLabel

Human papillomavirus-associate ...... nd a review of the literature.

@en

Human papillomavirus-associated cutaneous disease burden in human immunodeficiency virus

@nl

P1476

Human papillomavirus-associate ...... nd a review of the literature.

@en

P2093

Catherine Chung

http://www.w3.org/2001/XMLSchema#string

Lindsay C Bacik

http://www.w3.org/2001/XMLSchema#string

P2860

Achieving high coverage in Rwanda's national human papillomavirus vaccination programme

HPV Carcinomas in Immunocompromised Patients

HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs?

Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels

Human papillomavirus community in healthy persons, defined by metagenomics analysis of human microbiome project shotgun sequencing data sets

Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF.

Human Immunodeficiency Virus and Human Papilloma Virus - why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful.

Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells.

Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types.

Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women.

P31

scholarly article

P356

10.1111/IJD.13819

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29152727

http://www.w3.org/2001/XMLSchema#string